TIMMY Q NGUYEN
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology WESTON, FL NPI 1831243112
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology FL ImmunoGen, Inc. All categories
General Payments — all program years on this page
$51,180.15
- Category: General Payments
- Program years: PY2018–2024
- Record count: 176
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $15,745.09 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,590.00 | 3 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,070.00 | 1 |
| Honoraria | $1,715.00 | 1 |
| Food and Beverage | $1,202.61 | 46 |
| Travel and Lodging | $1,167.48 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ImmunoGen, Inc. | $6,845.00 | 1 |
| Exelixis Inc. | $2,959.88 | 10 |
| Acerta Pharma LLC | $2,808.31 | 5 |
| Ipsen Biopharmaceuticals, Inc | $2,321.94 | 4 |
| Janssen Biotech, Inc. | $174.49 | 6 |
| GlaxoSmithKline, LLC. | $112.77 | 6 |
| PFIZER INC. | $99.70 | 5 |
| TAIHO ONCOLOGY, INC. | $82.23 | 4 |
| Merck Sharp & Dohme Corporation | $53.68 | 3 |
| ABBVIE INC. | $49.11 | 2 |
| Tempus AI, Inc | $37.21 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.33 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.46 | 2 |
| Coherus Biosciences Inc. | $28.65 | 1 |
| AVEO Pharmaceuticals, Inc. | $24.71 | 1 |
| Genentech USA, Inc. | $22.77 | 1 |
| Daiichi Sankyo Inc. | $21.05 | 1 |
| EMD Serono, Inc. | $20.00 | 1 |
| EISAI INC. | $15.80 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.